Dr. John Wessner, M.D

NPI: 1497723423
Total Payments
$15,180
2024 Payments
$1,398
Companies
45
Transactions
1,012
Medicare Patients
14,086
Medicare Billing
$1.1M

Payment Breakdown by Category

Food & Beverage$14,582 (96.1%)
Education$597.48 (3.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,582 999 96.1%
Education $597.48 13 3.9%

Top Paying Companies

Company Total Records Latest Year
Lilly USA, LLC $1,787 153 $0 (2024)
Novo Nordisk Inc $1,777 127 $0 (2024)
Astellas Pharma US Inc $1,763 72 $0 (2024)
PFIZER INC. $1,114 78 $0 (2024)
AstraZeneca Pharmaceuticals LP $939.48 67 $0 (2024)
Janssen Pharmaceuticals, Inc $848.73 71 $0 (2024)
Amgen Inc. $803.68 46 $0 (2024)
GlaxoSmithKline, LLC. $721.51 49 $0 (2024)
Amarin Pharma Inc. $672.17 36 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $660.98 56 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,398 86 Lilly USA, LLC ($240.88)
2023 $1,835 117 Astellas Pharma US Inc ($263.96)
2022 $2,098 120 Lilly USA, LLC ($347.58)
2021 $2,071 137 Astellas Pharma US Inc ($244.74)
2020 $1,696 101 Astellas Pharma US Inc ($247.22)
2019 $1,545 105 Janssen Pharmaceuticals, Inc ($247.41)
2018 $2,227 160 Astellas Pharma US Inc ($389.13)
2017 $2,310 186 Novo Nordisk Inc ($406.69)

All Payment Transactions

1,012 individual payment records from CMS Open Payments — Page 1 of 41

Date Company Product Nature Form Amount Type
12/10/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $19.90 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/02/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $24.96 General
Category: PSYCHIATRY
11/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.33 General
Category: RESPIRATORY
11/14/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.75 General
Category: Cardiology
11/13/2024 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $18.56 General
Category: Spinal Cord Stimulator
10/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $25.33 General
Category: RESPIRATORY
10/23/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $18.88 General
Category: Cardiovascular
10/21/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $16.39 General
Category: PAIN
10/16/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.35 General
Category: Cardiology
10/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.64 General
Category: Respiratory
10/09/2024 Lilly USA, LLC Food and Beverage In-kind items and services $11.14 General
09/30/2024 Lilly USA, LLC Food and Beverage In-kind items and services $12.96 General
09/25/2024 Novo Nordisk Inc Rybelsus (Drug) Food and Beverage In-kind items and services $16.55 General
Category: Diabetes
09/25/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $10.55 General
Category: Diabetes
09/23/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $11.78 General
Category: VACCINES
09/16/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $11.34 General
Category: Diabetes
08/29/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.41 General
Category: RESPIRATORY
08/22/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.57 General
Category: Cardiology
08/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.11 General
Category: RESPIRATORY
08/20/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $19.66 General
Category: UROLOGY
08/14/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $0.95 General
Category: VACCINES
08/13/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $9.01 General
Category: VACCINES
08/08/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $18.58 General
Category: Respiratory
08/07/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $13.27 General
Category: Diabetes
08/05/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $16.12 General
Category: Cardiovascular

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 24 2,806 5,195 $402,752 $234,924
2022 25 3,252 5,977 $451,219 $266,513
2021 26 3,764 6,893 $498,345 $303,693
2020 27 4,264 7,770 $460,738 $281,125
Total Patients
14,086
Total Services
25,835
Medicare Billing
$1.1M
Procedure Codes
102

All Medicare Procedures & Services

102 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 535 1,541 $161,805 $84,514 52.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 378 378 $51,030 $45,821 89.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 265 373 $57,815 $27,921 48.3%
90662 Influenza vaccine split virus, preservative free Office 2023 188 188 $16,920 $13,519 79.9%
99497 Advance care planning, first 30 minutes Office 2023 163 163 $17,930 $12,119 67.6%
99496 Transitional care management services for problem of high complexity Office 2023 49 57 $15,675 $11,722 74.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 177 230 $14,950 $8,045 53.8%
96372 Injection of drug or substance under skin or into muscle Office 2023 233 791 $19,995 $6,812 34.1%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 23 23 $6,900 $6,487 94.0%
G0008 Administration of influenza virus vaccine Office 2023 192 192 $5,760 $5,472 95.0%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 31 33 $6,930 $5,021 72.4%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 55 70 $5,600 $2,631 47.0%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2023 32 49 $2,695 $1,407 52.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 11 11 $2,475 $1,167 47.2%
G0009 Administration of pneumococcal vaccine Office 2023 24 24 $600.00 $588.00 98.0%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2023 15 15 $865.00 $388.36 44.9%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 20 20 $400.00 $340.80 85.2%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 20 20 $400.00 $340.80 85.2%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 70 258 $3,096 $249.59 8.1%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2023 100 365 $5,475 $130.75 2.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 15 15 $825.00 $125.41 15.2%
81003 Automated urinalysis test Office 2023 29 36 $288.00 $79.20 27.5%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 170 274 $3,288 $21.85 0.7%
J1071 Injection, testosterone cypionate, 1 mg Office 2023 11 69 $1,035 $1.09 0.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 582 1,701 $178,605 $95,465 53.5%

About Dr. John Wessner, M.D

Dr. John Wessner, M.D is a Internal Medicine healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497723423.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wessner, M.D has received a total of $15,180 in payments from pharmaceutical and medical device companies, with $1,398 received in 2024. These payments were reported across 1,012 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,582).

As a Medicare-enrolled provider, Wessner has provided services to 14,086 Medicare beneficiaries, totaling 25,835 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Dothan, AL
  • Active Since 03/08/2006
  • Last Updated 08/26/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1497723423

Products in Payments

  • ELIQUIS (Drug) $1,205
  • Ozempic (Drug) $942.33
  • TRULICITY (Drug) $803.54
  • Vascepa (Drug) $672.17
  • JARDIANCE (Drug) $648.44
  • MYRBETRIQ (Drug) $645.87
  • ENTRESTO (Drug) $557.50
  • XARELTO (Drug) $554.02
  • FARXIGA (Drug) $531.19
  • MOUNJARO (Drug) $474.17
  • TRELEGY ELLIPTA (Drug) $472.07
  • Kerendia (Drug) $438.99
  • Myrbetriq (Drug) $312.34
  • XIFAXAN (Drug) $307.24
  • INVOKANA (Drug) $281.86
  • Victoza (Drug) $252.56
  • UBRELVY (Drug) $246.72
  • Tresiba (Drug) $243.12
  • BELSOMRA (Drug) $230.58
  • EVENITY (Biological) $211.56

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Dothan